• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Third party research

Clavister: Norwegian order showing benefits - ABG

Clavister

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* Defence order lifts Q1e sales to SEK 76m, +42% y-o-y
* Entering the new year with stronger financial fundamentals
* Expecting an average FCF yield 7% p.a. '26e-'28e

Strong quarter thanks to Norwegian order

This is the first quarter with the Norwegian order in place, a complete software implementation, resulting in our Q1 estimated sales of SEK 76m, or 42% y-o-y growth. While the defence order boosts the quarter, we think underlying growth will be held back by a soft civilian business. On top of this, we think ~SEK 10m in deliveries that were postponed from Q4'25 will largely land in Q1, although we expect these to carry a lower gross margin. With this, we estimate a Q1 gross margin of 77% and EBITDA of SEK 18m, for a 23% margin. Also worth noting is that we expect net financials to be much lower following the refinancing and removal of the EIB loan.

Some additional costs

Following a change of analyst, we slightly lower sales estimates for '26, but we increase sales and EBIT for '27e and '28e. The reason for our cut to EBIT for '26e is that we think the company will likely have some additional costs for the Norwegian order. We think this is natural given that the order we estimate as ~26% of group sales for this year. We have previously highlighted the scaling potential, and while this thesis remains intact, we believe growing and gaining market share is the more important priority for Clavister at this stage of its journey.

Exciting times ahead

Clavister has undergone exciting changes, refinancing its loan, winning a meaningful defence order and gaining market share in the civilian market. Looking ahead, the company now has much stronger finances for growing the business on entirely different terms, and with the growth intact, we estimate an avg. of ~7% FCF yield in our forecast period. The company is trading at EV/EBITDA of 17x/10x/7x for '26e/'27e/'28e, which is ~15% below peers.